Explore more publications!

Technology Digest Yemen: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Yemen.

Press releases published on December 22, 2025

Gartner® Recognizes Conifers as the Company to Beat in the Report "AI Vendor Race: Conifers Is the Company to Beat in AI SOC Agents for Threat Investigation," December 2025
Viewbix: Quantum X Labs Announces Provisional Patent Filing for Quantum-Enhanced Clinical Trials Technology
Wearable Devices Introduces Updates for the Mudra Link Application with Customized Presets and Enhanced Smart-Glasses Usability
AITX Subsidiary RAD-G Moves SARA From Proof of Concept to Paying Agentic AI Clients
IEEE SA Emerging Technology Award Recognizes Standards Working Group Founded and Co-Led by Waterfall Network Researchers on Recurring Payments on DLTs
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
EdgeMode Secure Strategic Power Milestone for Europe’s Largest AI Data Center Pipeline
Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
Peer to Peer Network, Inc. Announces Contract With Hopscotch Air® to Deploy Tier-1 AI Communications Suite
Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
Nasus Pharma CEO Issues 2025 Letter to Shareholders
RESTEM to Present Company Overview in Biotech Showcase 2026
EMulate Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating its Paclitaxel ulRFE® Signal to Extend Survival and Slow Tumor Growth in Diffuse Midline Glioma Animal Model
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O’Malley Jr. to its Board of Directors
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
Leading Quantum Scientists Join Zapata’s Scientific Advisory Board, Validating Its Software-First Approach

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions